The Leucadia Therapeutics staff has been working for a few years now to prove the founder’s hypothesis on the cause of Alzheimer’s disease. In this view, the primary problem is impaired drainage of cerebrospinal fluid. As the drainage path through the cribriform plate is blocked by slow ossification of channels, metabolic waste builds up in...
